Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1) MUMBAI, India and NAPLES, Fla., July 21, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the...
Hence then, the article about lupin spins out two oncology programs to kaveri therapeutics to advance its oncology strategy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy )
Also on site :
- ‘Scrubs’ Stars Zach Braff and Donald Faison Tease Fixing Fan Complaints and Nostalgic Cameos in Season 2 (Exclusive)
- Jim Carrey paid $16.5 million for a Maui beachfront estate in 2016; nearly a decade later he has listed the two-house compound on Keawakapu Beach for $35 million
- The Hunting Wives Renewed For Season 3 Ahead Of Season 2 Premiere On Netflix